Price loading...

The 2013-2018 Outlook for Irritable Bowel Syndrome (IBS) Therapeutics in the United States

Price data last checked 104 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications
Format
paperback
ASIN
B00E0VHF6C
Category
Books > Subjects > Business, Finance & Law > Economics > Econometrics
Domain
Amazon UK
Release Date
17 July 2013
Listed Since
23 July 2013

Similar Products You Might Like

The 2013-2018 Outlook for Endometriosis Treatments in the United States
96% match

The 2013-2018 Outlook for Endometriosis Treatments in the United States

£495.00 09 Jan 2026
The 2013-2018 Outlook for Metabolomics in the United States
95% match

The 2013-2018 Outlook for Metabolomics in the United States

£495.00 07 Jan 2026
The 2013-2018 Outlook for Testosterone Replacement Therapy (TRT) in the United States
95% match

The 2013-2018 Outlook for Testosterone Replacement Therapy (TRT) in the United States

£495.00 11 Jan 2026
The 2013-2018 Outlook for Hormone Replacement Therapy (HRT) in the United States
95% match

The 2013-2018 Outlook for Hormone Replacement Therapy (HRT) in the United States

£495.00 08 Jan 2026
The 2013-2018 Outlook for Online Travel Services in the United States
95% match

The 2013-2018 Outlook for Online Travel Services in the United States

£495.00 07 Jan 2026
The 2013-2018 Outlook for Enterprise Mobility Solutions in the United States
95% match

The 2013-2018 Outlook for Enterprise Mobility Solutions in the United States

£495.00 16 Dec 2025
The 2013-2018 Outlook for Interactive Voice Response (IVR) Systems in the United States
95% match

The 2013-2018 Outlook for Interactive Voice Response (IVR) Systems in the United States

£495.00 11 Jan 2026
The 2013-2018 Outlook for Enterprise Service Bus (ESB) Technologies in The Americas
95% match

The 2013-2018 Outlook for Enterprise Service Bus (ESB) Technologies in The Americas

£325.00 06 Feb 2026
The 2013-2018 Outlook for Chiral Technologies in the United States
95% match

The 2013-2018 Outlook for Chiral Technologies in the United States

£495.00 09 Feb 2026
The 2013-2018 Outlook for Digestion Aids in India
95% match

The 2013-2018 Outlook for Digestion Aids in India

£495.00 12 Jan 2026
The 2013-2018 Outlook for Mail Orders in the United States
95% match

The 2013-2018 Outlook for Mail Orders in the United States

£495.00 11 Jan 2026
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in The Americas
95% match

The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in The Americas

£325.00 14 Jan 2026
The 2013-2018 Outlook for Cell-Based Assays in the United States
95% match

The 2013-2018 Outlook for Cell-Based Assays in the United States

£495.00 09 Jan 2026
The 2013-2018 Outlook for Ambulatory and Bathroom Aids in North America & the Caribbean
95% match

The 2013-2018 Outlook for Ambulatory and Bathroom Aids in North America & the Caribbean

£325.00 01 Feb 2026
The 2013-2018 Outlook for Biobanks in the United States
95% match

The 2013-2018 Outlook for Biobanks in the United States

£495.00 07 Jan 2026
The 2023-2028 Outlook for Traveler's Diarrhea Therapeutics for US Zip Codes
95% match

The 2023-2028 Outlook for Traveler's Diarrhea Therapeutics for US Zip Codes

£490.00 24 Jan 2026
The 2023-2028 Outlook for Enteric Disease Testing-Treatment for US Zip Codes
95% match

The 2023-2028 Outlook for Enteric Disease Testing-Treatment for US Zip Codes

£490.00 13 Jan 2026
The 2013-2018 Outlook for Accounting, Auditing, and Bookkeeping Services in the United States
95% match

The 2013-2018 Outlook for Accounting, Auditing, and Bookkeeping Services in the United States

£495.00 13 Jan 2026
The 2013-2018 Outlook for Erythropoietins in North America & the Caribbean
95% match

The 2013-2018 Outlook for Erythropoietins in North America & the Caribbean

£325.00 21 Jan 2026
The 2013-2018 Outlook for Testosterone Replacement Therapy (TRT) in The Americas
95% match

The 2013-2018 Outlook for Testosterone Replacement Therapy (TRT) in The Americas

£325.00 07 Jan 2026
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States
95% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States

£495.00 08 Jan 2026
The 2013-2018 Outlook for Conjugated Linoleic Acid (CLA) in the United States
95% match

The 2013-2018 Outlook for Conjugated Linoleic Acid (CLA) in the United States

£495.00 12 Jan 2026
The 2013-2018 Outlook for Medical Robotics in the United States
95% match

The 2013-2018 Outlook for Medical Robotics in the United States

£495.00 14 Jan 2026
The 2013-2018 Outlook for Cloud Computing Services in the United States
95% match

The 2013-2018 Outlook for Cloud Computing Services in the United States

£495.00 23 Feb 2026